Tuberculosis-Diabetes Co-Morbidity Is Characterized by Heightened Systemic Levels of Circulating Angiogenic Factors

Journal of Infection - United Kingdom
doi 10.1016/j.jinf.2016.08.021
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Profiling Leucocyte Subsets in Tuberculosis-Diabetes Co-Morbidity

Immunology
AllergyImmunology
2015English

Serum Levels of Three Angiogenic Factors in Systemic Lupus Erythematosus and Their Clinical Significance

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

Role of Circulating Angiogenic Factors in Diabetic Kidney Disease

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
Medicine
2013English

Maternal Circulating Angiogenic Factors in Twin and Singleton Pregnancies

American Journal of Obstetrics and Gynecology
GynecologyObstetrics
2015English

Inflammatory Stays Inflammatory: A Subgroup of Systemic Sclerosis Characterized by High Morbidity and Inflammatory Resistance to Cyclophosphamide

Arthritis Research & Therapy
2019English

Resuscitation of Dormant “Non-Culturable” Mycobacterium Tuberculosis Is Characterized by Immediate Transcriptional Burst

Frontiers in Cellular and Infection Microbiology
MedicineInfectious DiseasesImmunologyMicrobiology
2019English

Influence of High Density Lipoprotein Cholesterol Levels on Circulating Monocytic Angiogenic Cells Functions in Individuals With Type 2 Diabetes Mellitus

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2018English

Study of Hypertensive Subjects With Diabetes as Co-Morbidity

International Journal of Research in Medical Sciences
2017English

The Levels of Circulating Proangiogenic Factors in Migraineurs

NeuroMolecular Medicine
Molecular NeuroscienceNeurologyMolecular MedicineCellular
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy